BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 230533)

  • 1. Human lymphocyte subpopulations.
    Vogler LB; Grossi CE; Cooper MD
    Prog Hematol; 1979; 11():1-45. PubMed ID: 230533
    [No Abstract]   [Full Text] [Related]  

  • 2. Markers of human lymphocyte subpopulations in primary immunodeficiency and lymphoproliferative disorders.
    Gupta S; Good RA
    Semin Hematol; 1980 Jan; 17(1):1-29. PubMed ID: 6244677
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of human peripheral blood lymphocyte cells on the basis of surface properties.
    Negro Alvarez JM
    Allergol Immunopathol (Madr); 1980; 8(6):679-84. PubMed ID: 7010971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Subpopulations of human lymphocytes differing in receptors to mouse and sheep red blood cells.
    Kunicka J; Matej H
    Arch Immunol Ther Exp (Warsz); 1983; 31(4):409-16. PubMed ID: 6367695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deficiency of Epstein-Barr virus (EBV) receptors on B lymphocytes from certain patients with common varied agammaglobulinemia.
    Schwaber JF; Klein G; Ernberg I; Rosen A; Lazarus H; Rosen FS
    J Immunol; 1980 May; 124(5):2191-6. PubMed ID: 6245136
    [No Abstract]   [Full Text] [Related]  

  • 6. In situ characterization of cell infiltrates in the dermis of human scabies.
    Falk ES; Matre R
    Am J Dermatopathol; 1982 Feb; 4(1):9-15. PubMed ID: 7044174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surface markers and functional characteristics of human blood lymphocytes residing in the operational "null" subset.
    Bakács T; Klein E; Steinitz M; Gergely P
    Haematologia (Budap); 1978-1979; 12(1-4):113-26. PubMed ID: 231548
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [C3 receptor expression in lymphocytes].
    Kudo T; Okuda T; Tachibana T
    Nihon Rinsho; 1979 May; 37(5):993-1001. PubMed ID: 224224
    [No Abstract]   [Full Text] [Related]  

  • 9. Study of human T and B lymphocytes with heterologous antisera. IV. Subpopulations in tonsil and adenoid cell suspensions.
    Brochier J; Samarut C; Bich-Thuy LT; Revillard JP
    Immunology; 1978 Nov; 35(5):827-35. PubMed ID: 309859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effect of T and B lymphocytes on the phagocytic activity of polymorphonuclear neutrophils in human peripheral blood].
    Snastina TI; Belotskiĭ SM
    Biull Eksp Biol Med; 1982 Nov; 94(11):80-2. PubMed ID: 6983898
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lymphocyte subpopulations in healthy and unhealthy newborn babies.
    Ansanelli V; Benedetto N; Di Lena C; Galdiero F; Jafusco F
    Boll Ist Sieroter Milan; 1982; 61(4):336-46. PubMed ID: 6985420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical relevance of lymphocyte surface markers in leukemia and lymphoma.
    Bloomfield CD; Gajl-Peczalska KJ
    Curr Top Hematol; 1980; 3():175-240. PubMed ID: 6276102
    [No Abstract]   [Full Text] [Related]  

  • 13. Identification of human lymphocyte subpopulations by surface marker analysis.
    Ross GD
    Blood; 1979 May; 53(5):799-811. PubMed ID: 219922
    [No Abstract]   [Full Text] [Related]  

  • 14. Activation of lymphocytes by a thiol-derivatized nucleoside: characterization of cellular parameters and responsive subpopulations.
    Goodman MG; Weigle WO
    J Immunol; 1983 Feb; 130(2):551-7. PubMed ID: 6600242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surface markers for characterisation of bovine blood lymphocyte populations and changes in these from birth to maturity.
    Outteridge PM; Dufty JH
    Res Vet Sci; 1981 Nov; 31(3):315-22. PubMed ID: 6210941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of a human B cell-specific antigen (B2) distinct from B1.
    Nadler LM; Stashenko P; Hardy R; van Agthoven A; Terhorst C; Schlossman SF
    J Immunol; 1981 May; 126(5):1941-7. PubMed ID: 6163824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human lymphocyte differentiation markers and their application to immune deficiency and lymphoproliferative diseases.
    Siegal FP; Good RA
    Clin Haematol; 1977 Jun; 6(2):355-422. PubMed ID: 334421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of antigen presentation after antigen targeting to surface IgD, IgM, MHC, Fc gamma RII, and B220 molecules on murine splenic B cells.
    Snider DP; Segal DM
    J Immunol; 1989 Jul; 143(1):59-65. PubMed ID: 2471743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunological diagnosis of acute lymphoblastic leukemia].
    Shalaev VA
    Gematol Transfuziol; 1986 Jun; 31(6):51-5. PubMed ID: 3525320
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunobiology of CR2, the B lymphocyte receptor for Epstein-Barr virus and the C3d complement fragment.
    Cooper NR; Moore MD; Nemerow GR
    Annu Rev Immunol; 1988; 6():85-113. PubMed ID: 2838050
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.